CT monitoring of chemotherapeutic agent delivery after osmotic blood brain barrier disruption.
D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000378:metabolism*; D001812:Blood-Brain Barrier / Q000187:drug effects*; D001932:Brain Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy*; D004285:Dogs; D006801:Humans; D007269:Injections, Intra-Arterial; D007278:Injections, Spinal; D008727:Methotrexate / Q000008:administration & dosage / Q000378:metabolism; D014057:Tomography, X-Ray Computed
D000970:Antineoplastic Agents; D008727:Methotrexate